These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25989916)

  • 1. Gender differences in outpatients with anxiety disorders: the Leiden Routine Outcome Monitoring Study.
    Pesce L; van Veen T; Carlier I; van Noorden MS; van der Wee NJ; van Hemert AM; Giltay EJ
    Epidemiol Psychiatr Sci; 2016 Jun; 25(3):278-87. PubMed ID: 25989916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reference values for generic instruments used in routine outcome monitoring: the Leiden Routine Outcome Monitoring Study.
    Schulte-van Maaren YW; Carlier IV; Zitman FG; van Hemert AM; de Waal MW; van Noorden MS; Giltay EJ
    BMC Psychiatry; 2012 Nov; 12():203. PubMed ID: 23171272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measuring treatment outcome in patients with anxiety disorders: A comparison of the responsiveness of generic and disorder-specific instruments.
    Schawo SJ; Carlier IVE; van Hemert AM; de Beurs E
    J Anxiety Disord; 2019 May; 64():55-63. PubMed ID: 30986658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting outcomes of mood, anxiety and somatoform disorders: the Leiden routine outcome monitoring study.
    van Noorden MS; van Fenema EM; van der Wee NJ; van Rood YR; Carlier IV; Zitman FG; Giltay EJ
    J Affect Disord; 2012 Dec; 142(1-3):122-31. PubMed ID: 22840464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concordance between self-reported and observer-rated anxiety severity in outpatients with anxiety disorders: The Leiden routine outcome monitoring study.
    Schat A; van Noorden MS; Giltay EJ; Noom MJ; Vermeiren RRJM; Zitman FG
    Psychol Psychother; 2017 Dec; 90(4):705-719. PubMed ID: 28737269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence, demographic and clinical characteristics of body dysmorphic disorder among psychiatric outpatients with mood, anxiety or somatoform disorders.
    van der Meer J; van Rood YR; van der Wee NJ; den Hollander-Gijsman M; van Noorden MS; Giltay EJ; Zitman FG
    Nord J Psychiatry; 2012 Sep; 66(4):232-8. PubMed ID: 22029732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Age-related characteristics of outpatients with anxiety disorders: the Leiden routine outcome monitoring study.
    Schat A; van Noorden MS; van Amelsvoort T; Giltay EJ; van der Wee NJA; Noom MJ; Vermeiren RRJM; Zitman FG
    Int J Psychiatry Clin Pract; 2017 Nov; 21(4):307-313. PubMed ID: 28622045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Course Comparison Between Anxiety-Related Disorders in Adult Outpatients: A Leiden Routine Outcome Monitoring Study.
    Carlier IVE; van der Elst LV; de Jong K; van Vliet IM
    J Nerv Ment Dis; 2023 Aug; 211(8):601-612. PubMed ID: 37166241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different Clinical Expression of Anxiety Disorders in Children and Adolescents: Assessment and Treatment.
    Pop-Jordanova N
    Pril (Makedon Akad Nauk Umet Odd Med Nauki); 2019 May; 40(1):5-40. PubMed ID: 31152643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Comorbidity in 207 cannabis users in a specific outpatient setting].
    Guillem E; Arbabzadeh-Bouchez S; Vorspan F; Bellivier F
    Encephale; 2015 Jun; 41 Suppl 1():S7-12. PubMed ID: 25123065
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief Symptom Inventory symptom profiles of outpatients with borderline intellectual functioning and major depressive disorder or posttraumatic stress disorder: Comparison with patients from regular mental health care and patients with Mild Intellectual Disabilities.
    Wieland J; Zitman FG
    Res Dev Disabil; 2016; 51-52():153-9. PubMed ID: 26827151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of prolonged treatment course for depressive and anxiety disorders in an outpatient setting: The Leiden routine outcome monitoring study.
    Boer S; Dekkers OM; Cessie SL; Carlier IV; van Hemert AM
    J Affect Disord; 2019 Mar; 247():81-87. PubMed ID: 30658244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of suicidal outpatients with mood, anxiety and somatoform disorders: The role of childhood abuse and neglect.
    Carlier IV; Hovens JG; Streevelaar MF; van Rood YR; van Veen T
    Int J Soc Psychiatry; 2016 Jun; 62(4):316-26. PubMed ID: 26896029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of posttraumatic symptoms and comorbid mental disorders on the health-related quality of life in treatment-seeking PTSD patients.
    Pagotto LF; Mendlowicz MV; Coutinho ES; Figueira I; Luz MP; Araujo AX; Berger W
    Compr Psychiatry; 2015 Apr; 58():68-73. PubMed ID: 25656798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reference values for anxiety questionnaires: the Leiden Routine Outcome Monitoring Study.
    Schulte-van Maaren YW; Giltay EJ; van Hemert AM; Zitman FG; de Waal MW; Carlier IV
    J Affect Disord; 2013 Sep; 150(3):1008-18. PubMed ID: 23810480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reliability and validity of the DSM-5 Anxious Distress Specifier Interview.
    Zimmerman M; Clark H; McGonigal P; Harris L; Holst CG; Martin J
    Compr Psychiatry; 2017 Jul; 76():11-17. PubMed ID: 28384524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse childhood experiences in relation to mood and anxiety disorders in a population-based sample of active military personnel.
    Sareen J; Henriksen CA; Bolton SL; Afifi TO; Stein MB; Asmundson GJ
    Psychol Med; 2013 Jan; 43(1):73-84. PubMed ID: 22608015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of Post-traumatic Stress Disorder: validation of a measure, the PCLS].
    Yao SN; Cottraux J; Note I; De Mey-Guillard C; Mollard E; Ventureyra V
    Encephale; 2003; 29(3 Pt 1):232-8. PubMed ID: 12876547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinically useful self-report measure of the DSM-5 anxious distress specifier for major depressive disorder.
    Zimmerman M; Chelminski I; Young D; Dalrymple K; Walsh E; Rosenstein L
    J Clin Psychiatry; 2014 Jun; 75(6):601-7. PubMed ID: 24813209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine treatment of depressed patients with comorbid anxiety disorders.
    Sonawalla SB; Farabaugh A; Johnson MW; Morray M; Delgado ML; Pingol MG; Rosenbaum JF; Fava M
    J Psychopharmacol; 2002 Sep; 16(3):215-9. PubMed ID: 12236627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.